US · Healthcare

Elicio Therapeutics Inc. (ELTX)

Biotechnology

Elicio Therapeutics Inc. (ELTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ELTX

P/E ratio

25.00

Elicio Therapeutics Inc. (ELTX) — FAQ

What is ELTX's P/E ratio?

The price-to-earnings (P/E) ratio for Elicio Therapeutics Inc. (ELTX) is 25.00 (data as of 2026-05-23).

Does Elicio Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Elicio Therapeutics Inc. (ELTX). Check the MyAverix Finance app for the latest dividend data.

What sector is Elicio Therapeutics Inc. in?

Elicio Therapeutics Inc. (ELTX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ELTX listed on?

ELTX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)